Activity of the β-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism
Authors:
- Julia GigerJGJulia Giger
- Anqi X. QinAQAnqi X. Qin
- Paul W. BodellPBPaul W. Bodell
- Kenneth M. BaldwinKBKenneth M. Baldwin
- Fadia HaddadFHFadia Haddad
Open Access
- 1 June 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 292 (6) , H3065-H3071
Abstract
Two genes encoding cardiac myosin heavy chain (MHC) isoforms, β and α, are arranged in tandem 4.5 kb apart. We examined pre-mRNA and mature mRNA levels of β and α genes in control, diabetic (streptozotocin), hypothyroid (propylthiouracil), and hyperthyroid rat hearts and analyzed the naturally occurring antisense (AS) β RNA species that starts in the middle of the 4.5-kb intergenic region and extends upstream to the β-gene promoter. The β and α genes are expressed antithetically in control, diabetic, hypothyroid, and hyperthyroid hearts. Expression of AS β-RNA was positively correlated with α-mRNA and negatively correlated with sense β mRNA. These results support the novel idea of common promoter-regulatory elements situated in the intergenic region that likely control transcription of both sense α and AS β genes and that AS β transcription negatively regulates β-MHC gene expression. To test whether an intergenic promoter drives transcription of AS β RNA, a 1340-bp sequence of the intergenic region was inserted into a luciferase plasmid in the 3′-to-5′ AS direction and was injected into rat ventricle. This promoter was activated in control heart and decreased greatly in response to propylthiouracil and streptozotocin and increased in hyperthyroid rats, similar in pattern to the endogenous AS β RNA. When a putative retinoic acid receptor (RAR) site (a known thyroid hormone receptor cofactor) in this promoter was mutated, the reporter activity was almost abolished in control, propylthiouracil, and streptozotocin hearts. We conclude that there is an intergenic promoter that is active in the AS direction and that the putative RAR element is a vital regulatory site.Keywords
This publication has 39 references indexed in Scilit:
- Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overloadAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- The silence RNA keeps: cis mechanisms of RNA mediated epigenetic silencing in mammalsPhilosophical Transactions of the Royal Society B: Biological Sciences, 2005
- Effect of unloading on type I myosin heavy chain gene regulation in rat soleus muscleJournal of Applied Physiology, 2005
- Effect of cyclosporin A treatment on the in vivo regulation of type I MHC gene expressionJournal of Applied Physiology, 2004
- Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expressionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heartEndocrinology, 1996
- Anin vivo analysis of transcriptional elements in the mouse α-myosin heavy chain gene promoterTransgenic Research, 1995
- Thyroid Hormone Influences Beta Myosin Heavy Chain (βMHC) ExpressionBiochemical and Biophysical Research Communications, 1994
- Thyroid hormone regulation of alpha-myosin heavy chain promoter activity assessed by invivo DNA transfer in rat heartBiochemical and Biophysical Research Communications, 1991
- Differential regulation by thyroid hormones of myosin heavy chain α and β mRNAs in the rat ventricular myocardiumJournal of Endocrinology, 1989